After a reported 2.1% growth in consolidated gross premium returns for both Fukoku Life and its standalone subsidiary Fukokushinrai Life, from JPY580.9bn ($3.9bn) in 9M2024 to JPY592.8bn in 9M2024, CreditSights has revised its recommendation for the company from Market perform to Outperform.